However, our data did not show any significant difference in the tumor cell apoptosis rates for primary OSCC with high and low levels of DR4 and/or DR5 expression, or for differential expression levels of decoy receptors DcR1 and DcR2. The gene discussed is TNFRSF10A; the disease is neoplasm.